Medlive Technology Co., Ltd. operates an online professional physician platform in Mainland China and internationally. The company's precision marketing and corporate solution provides digital marketing, digital detailing, digital marketing consultation, digital content creation, application software development, and other relevant services. Its medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians and other registered users, such as other healthcare professionals and pharmaceutical companies. The company's intelligent patient management solutions include single disease management services, such as disease knowledge dissemination and treatment compliance monitoring; patient education services comprising content development, application software development, and other related services; and chronic disease management services for breast cancer, lung cancer, ovarian cancer, Parkinson's, lymphoma, stroke, and diabetes management. In addition, it is involved in the provision of research and development services; provision of internet hospital services; provision of publication and planning services for medicine guidelines and medical consensus; organizing medical exhibition conferences; provision of medical services; and provision of research services to pharmaceutical companies. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in February 2021. The company was founded in 1996 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Medlive Technology Co Ltd (2192) operate in?
Medlive Technology Co Ltd belongs to the Healthcare sector and operates in the Health Information Services industry.
What is Medlive Technology Co Ltd (2192) current stock price?
As of the latest data, Medlive Technology Co Ltd stock price is HK$7.04, with a previous close of HK$6.91. Medlive Technology Co Ltd gained HK$0.13 in the last trading session, representing a 1.81% increase.
What is Medlive Technology Co Ltd (2192) current market capitalization?
Medlive Technology Co Ltd market cap is approximately 5.21 billion.
What is Medlive Technology Co Ltd (2192) EBITDA?
Medlive Technology Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 93.26 million.
Does Medlive Technology Co Ltd (2192) pay dividends?
Yes. Medlive Technology Co Ltd pays semiannual dividends with an annualized yield of 4.3% and an estimated annual payout of HK$0.30 per share.
When is the next ex-dividend date for Medlive Technology Co Ltd (2192)?
The next ex-dividend date is scheduled for September 10, 2026.
What is Medlive Technology Co Ltd (2192) beta (volatility) score?
Medlive Technology Co Ltd has a beta of 0.439, indicating lower volatility than the overall market.